Abstract:Androgenetic alopecia affects both men and women. In men it produces male pattern hair loss with bitemporal recession and vertex baldness. In women it produces female pattern hair loss (FPHL) with diffuse alopecia over the mid-frontal scalp. FPHL occurs as a result of nonuniform hair follicle miniaturization within follicular units. Diffuse alopecia is produced by a reduction in the number of terminal fibres per follicular unit. Baldness occurs only when all hairs within the follicular units are miniaturized and is a relatively late event in women. The concepts of follicular units and primary and secondary hair follicles within follicular units are well established in comparative mammalian studies, particularly in sheep. However, discovery of these structures in the human scalp hair and investigation of the changes in follicular unit anatomy during the development of androgenetic alopecia have provided a clearer understanding of the early stages of androgenetic alopecia and how the male and female patterns of hair loss are related. FPHL is the most common cause of alopecia in women and approximately one-third of adult caucasian women experience hair loss. The impact of FPHL is predominantly psychological. While men anticipate age-related hair loss, hair loss in women is usually unexpected and unwelcome at any age. Treatment options to arrest hair loss progression and stimulate partial hair regrowth for FPHL include the androgen receptor antagonists spironolactone and cyproterone acetate, the 5α-reductase inhibitor finasteride and the androgen-independent hair growth stimulator minoxidil. These treatments appear to work best when initiated early. Hair transplantation should be considered in advanced FPHL that is resistant to medical treatments. Hair transplantation requires well-preserved hair growth over the occipital donor area. The psychological impact of FPHL may also be reduced by cosmetic products that improve the appearance of the hair. These agents work to minimize hair fibre breakage, improve hair volume or conceal visible bald scalp.

[Androgenetic alopecia: where do we stand in 2024?]

Medical Treatment for Androgenetic Alopecia

A review of the treatment of male pattern hair loss

Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics

Androgenetic Alopecia: Therapy Update

Medical and procedural treatment of androgenetic alopecia - Where are we?

A Focus on Androgenetic Alopecia

Androgenetic alopecia: An update

Androgenetic Alopecia: A Review

Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness

Updated Review of Treatment of Androgenetic Alopecia

The Therapeutic Progress of Androgenetic Alopecia

Molecular mechanisms of androgenetic alopecia

How to treat androgenetic alopecia – the most common form of hair loss. A review

Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women

Types and Treatment of Hair Loss in Men and Women

Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options

Management of androgenic alopecia: a systematic review of the literature

Advanced Medical Therapies in the Management of Non-Scarring Alopecia: Areata and Androgenic Alopecia

Status of research on the development and regeneration of hair follicles

Drug discovery for alopecia: gone today, hair tomorrow